| Name | Title | Contact Details |
|---|
Lightcast is a global leader in labor market analytics, formed from the merger of Burning Glass Technologies and EMSI in 2021 and rebranded in 2022. The company provides comprehensive insights into the labor market through advanced data analytics, focusing on skills, jobs, supply, and demand worldwide. Lightcast offers a variety of services, including data integration from government and private sources, job postings analysis for real-time labor market trends, and profiles and skills analysis to address skills gaps. Their software platform combines tools for analyzing labor market trends and forecasting educational program demand. Additionally, Lightcast provides customizable dashboards for effective data visualization. The company serves educational institutions, government agencies, and businesses, helping them align their offerings with current job demands. Recent developments include becoming a Workday Certified Partner and joining the Snowflake Marketplace, enhancing their integration capabilities.
Phi Chi Theta Professional Business Fraternity - Zeta Omicron Chapter located at the University of California, Riverside. We: -Provide an opportunity to develop and practice professional leadership skills. -Provide a local and national network to share resources, ideas and concepts. -Practice values which will enable participation in a rapidly changing world. -Enable members to develop the business astuteness necessary to achieve high esteem and success in their chosen field.
Opening pathways to growth through learning programs for people both personally and professionally. We specialize in meeting the learning needs of people like you.
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
JIM ANTHONY GARCIA is a La Habra, CA-based company in the Business Services sector.